Home / lung

lung

June 23, 2025

The role of ultrasound in lung disease

Thoracic ultrasound (TUS) has emerged as an invaluable tool in the diagnosis and management of lung disease. Historically underutilised, advancements in ultrasound technology have revolutionised its application in pulmonary medicine. The lung, predominantly an air-filled organ, does not traditionally lend itself to direct ultrasound imaging; however, the presence of interstitial fluid, pleural effusion, consolidation or […]

Dr Syed Muhammed Zubair, Dr Raja Reddy

Kettering General Hospital NHS Foundation Trust

Read Article

June 12, 2024

Autocontouring for heart sparing lung radiotherapy

Lung cancer is the leading cause of cancer death in the UK and radiotherapy is an important treatment option, particularly for patients who are not well enough to have surgery. The importance of dose to the heart from lung radiotherapy is increasingly recognised. Recent research from our group at Manchester shows that giving radiation to […]

Dr Tom Marchant

The Christie NHS Foundation Trust

Read Article

January 17, 2024

Developments in lung SABR

The use of stereotactic ablative radiotherapy (SABR) has expanded in the UK over the past decade. In 2008, the UK SABR Consortium was established to help achieve a consensus in implementing and developing SABR in a safe and managed way. In 2011, the National Radiotherapy Implementation Group (NRIG) report recommended that SABR had become standard […]

Caroline Maguire, Kyle Woods, Dr Crispin Hiley

University College London Hospital; GenesisCare

Read Article

September 13, 2023

Abdominal compression evaluation for abdominal and lower lobe lung SABR using a compression belt system

Abdominal compression (AC) is a simple and effective method of reducing diaphragmatic motion and is widely used in abdominal stereotactic ablative body radiotherapy (SABR) delivery. It is not a new method of restricting motion; however, with the increase in SABR treatments there has been much interest in adopting this technique. Furthermore, there is some evidence […]

Louise Turtle, Michelle Forshaw, Andrew Willett

The Clatterbridge Cancer Centre

Read Article

March 16, 2022

The basics of lung ultrasound

In 2008 Daniel Lichtenstein demonstrated the diagnostic capabilities of lung ultrasound in the breathless patient. More recently the COVID-19 pandemic has increased awareness and uptake of this bedside imaging modality. It has been shown to out-perform chest radiography in the identification of specific lung abnormalities and is effectively performed at the bedside usually by the […]

Dr Jennie Stephens

Royal Cornwall Hospital

Read Article

April 19, 2019

Time of flight versus Q.Clear PETCT use in the assessment of lung nodules

The Herder model was first proposed by Herder et al in 2005 as a method of assessing nodule risk. The authors intended for this to be an improved, more accurate version of the Mayo model, which was used commonly to assess the malignancy risk of lung nodules. Herder et al proposed that they could accurately […]

Dawn Assaf, David Little, Stewart Redman, Matthew Jaring, Richard Graham

Royal United Hospitals Bath NHS Foundation Trust

Read Article

December 14, 2018

PETCT and lung cancer: Selecting those likely to benefit and sparing those with little to gain

Lung cancer is the third commonest cancer in the UK and 75% of patients present with advanced disease (stage III or IV); 10-year survival is only 5%. PETCT is best considered as a tool that aids the selection of those most likely to benefit from potentially curative treatment, either surgical resection or radical radiotherapy, while […]

Dr Peter J G Garmany

Queen Elizabeth University Hospital and West of Scotland Cancer Centre

Read Article

October 17, 2014

Bronchial artery embolisation in cystic fibrosis patients

Cystic fibrosis (CF) is a recessive genetic disease characterised by impaired mucociliary clearance. Although the disease affects multiple organs, 85% of mortality results from lung pathology relating to persistent recurrent infections, an exaggerated inflammatory response and progressive airways obstruction which ultimately leads to respiratory failure. Haemoptysis is a common symptom of CF with reported rates […]

Dr N Shaida

Addenbrooke's Hospital

Read Article